The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Rothman John F since 2007.
The trader's CIK number is 1238323.
At the time of the last reporting, Rothman John F was the VP of Clinical Devel of Advaxis, Inc.. (stock ticker symbol ADXS).
Also see all insider trading activities at Advaxis, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2007 | ADXS | 195,775 | $32,544 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-10-25 | ADXS | Buy | 61,043 | .18 | 10,987 |
| 2007-02-23 | ADXS | Buy | 134,732 | .16 | 21,557 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rothman John F (VP of Clinical Devel of Advaxis, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.